| 000 | 01768 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514201705.0 | ||
| 264 | 0 | _c20041130 | |
| 008 | 200411s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/424524 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDragunsky, Eugenia M | |
| 245 | 0 | 0 |
_aEvaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cOct 2004 |
||
| 300 |
_a1404-12 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 |
_aPoliomyelitis _xblood |
| 650 | 0 | 4 |
_aPoliovirus _xgenetics |
| 650 | 0 | 4 |
_aPoliovirus Vaccine, Inactivated _xadministration & dosage |
| 650 | 0 | 4 |
_aPoliovirus Vaccine, Oral _xadministration & dosage |
| 650 | 0 | 4 | _aVaccination |
| 700 | 1 | _aIvanov, Alexander P | |
| 700 | 1 | _aWells, Virgen R | |
| 700 | 1 | _aIvshina, Anna V | |
| 700 | 1 | _aRezapkin, Gennady V | |
| 700 | 1 | _aAbe, Shinobu | |
| 700 | 1 | _aPotapova, Svetlana G | |
| 700 | 1 | _aEnterline, Joan C | |
| 700 | 1 | _aHashizume, Sou | |
| 700 | 1 | _aChumakov, Konstantin M | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 190 _gno. 8 _gp. 1404-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/424524 _zAvailable from publisher's website |
| 999 |
_c15071735 _d15071735 |
||